Choksi Laboratories Ltd Stock Analysis

BSE: 526546 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price Aug 19, 18:03
30.10 1.30 (4.51%)

DeciZen - Make an Informed Decision on Choksi Lab

M-Cap below 100cr DeciZen not available

Choksi Lab Price Chart

P/E Ratio (SA) :
Market Cap :
20.1 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Choksi Laboratories Ltd a good quality company?

Data is not available for this company.

2. Is Choksi Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Choksi Laboratories Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Choksi Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Choksi Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Choksi Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

ROCE % 8%6.8%6.6%5.3%5.1%5.1%7.4%7.1%-0.8%-1.2%-
Value Creation Index -0.4-0.5-0.5-0.6-0.6-0.6-0.5-0.5-1.1-1.1-

Growth Parameters

Growth Parameters Colour Code Guide

YoY Gr. Rt. %-12.3%16.3%10.5%1.5%29%8.5%8.2%-16.6%-8.8%-
YoY Gr. Rt. %-2.6%4.5%-50.9%45%-20.7%110.9%18%-206.1%NA-
BVPS (₹) 26.728.329.227.728.830.332.234.52925.526.1
Adj Net Profit
Cash Flow from Ops.
Debt/CF from Ops. 2435.121.722.4116.1-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6%2.9%-6.3%-8.8%
Adj EPS -210.5%-226.3%-224.4%NA
BVPS -0.5-2.4-7.5-12.2
Share Price 12.8% 9.1% 29.4% 71%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity %
Op. Profit Mgn % 24.92321.723.423.316.620.321.512.616.133.1
Net Profit Mgn %
Debt to Equity
Working Cap Days 2091952112222441811491742212190
Cash Conv. Cycle 5674888165261385190

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.40%

Sales growth is good in last 4 quarters at 27.46%

Sales growth has been subdued in last 3 years -6.27%

Net Profit has been subdued in last 3 years -224.35%

Debt to equity has increased versus last 3 years average to 2.04

Latest Financials - Choksi Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 2.9 -
TTM Sales (₹ Cr.) 32.9 -
BVPS (₹.) 26.1 -
Reserves (₹ Cr.) 11 -
P/BV 1.10 -
PE 9.83 -
From the Market
52 Week Low / High (₹) 15.70 / 35.30
All Time Low / High (₹) 0.50 / 98.35
Market Cap (₹ Cr.) 20.1
Equity (₹ Cr.) 7
Face Value (₹) 10
Industry PE 61.6

Management X-Ray of Choksi Lab :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Login/Register to view analysis.

Key Ratios of Choksi Lab

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


About Choksi Laboratories Ltd

Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

CLL is a contract testing and analysis laboratory based in Indore, Central India. It analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals etc. It also help industries in their research processes. Its environment consultancy division helps firms in keeping the environment clean and free from pollution.

CLL was the first to develop Vendor Assessment programme in the edible oil extraction industry. The first to start water and soil analysis in Central India, also the first to start instrument calibration services for organizations that were targeting ISO certification or had already achieved it. The only one to commission and run, probably the largest Effluent Treatment Plant in India, at ONGC's Amod oil rig.

Quality products are a function of better raw materials and quality procedures.  CLL currently has facilities for analysis of over 1000 products and materials, with more being added every day.

A vast updated database of test specifications derived from AOAC, USP, BP, CP, EP, IP, IS, EPA, PFA, Food Chemicals Codex, AOCS, and several in-house methods, serves a wide spectrum of products and materials – pharmaceutical raw materials and formulations, agro products and their derivatives, fertilizers, pesticides, edible and industrial oils, chemicals, paints and dyes.

Last year, CLL provided its services to more than 1,000 customers world-wide. Driving this accelerated growth is a hard-working people-force of 200+ CLL personnel. They are young (The average age in CLL is below 30 years). They are determined. And they have a huge appetite for learning. Mostly from the University town of Indore, these graduates undergo a rigorous six month training at their lab. Once inducted, continuous training programmes take over - both internal as well as external. And finally the long painful process of getting these qualified personnel approved as FDA, BIS, MoEF - whatever their respective fields demand. In fact, one thing that they are quite known for is their excellent human resource pool. So much so that the surrounding companies keep playing bait to our experienced staff. Though it is quite a nuisance at times, it also does us proud when they are recognized and accepted in regional companies, and multinationals alike.

Services offered by the company:

  • Contract Laboratory Services (CLS):-Pharmaceutical Analysis-Food & Beverages Analysis-Water Analysis-Construction Material Analysis
  • Instrument Calibration & Validation Services
  • Environment Management Services
  • Clinical Research
  • Consultancy  
  • Assaying & Hallmarking


  • IPCA Laboratories
  • Nicholas Piramal India Ltd.
  • Serum Institute of India
  • Famycare India

Achievements/ recognition:

  • CLL is certified by BIS (Bureau of Indian Standards), FDA (Food and Drugs control Administration), MoEF (Ministry of Environment & Forests), State Pollution Control Boards (Gujarat and Madhya Pradesh State Pollution Control Boards), Department of Health(MP), Agricultural Marketing Advisor (AGMARK - GOI), and several other regulatory bodies.
  • CLL has also been accredited by NABL (National Accreditation Board for testing & calibration Laboratories). This is internationally recognized through ILAC (International Laboratory Accreditation Committee) and is based on ISO/IEC 17025 guidelines.
  • ISO/IEC 17025 : 2005Ministry of Environment & Forests (MoEF), India
  • Bureau of Indian Standards (BIS), India
  • Export Inspection Council (EIC), India
  • AGMARK, IndiaGold & Silver Assaying & Hallmarking Center (approved by Bureau of Indian Standards)
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now